Is there a Bearish outlook for Bemis Company, Inc. (NYSE:BMS) this week?

Bemis Company, Inc. (NYSE:BMS) LogoInvestors sentiment decreased to 0.91 in 2018 Q2. Its down 0.02, from 0.93 in 2018Q1. It dropped, as 28 investors sold Bemis Company, Inc. shares while 98 reduced holdings. 29 funds opened positions while 86 raised stakes. 65.20 million shares or 1.40% more from 64.30 million shares in 2018Q1 were reported.
Credit Suisse Ag invested in 0% or 85,471 shares. Tru Of Vermont owns 7,088 shares or 0.03% of their US portfolio. Texas Permanent School Fund holds 58,718 shares. Heartland Advisors has invested 0.02% in Bemis Company, Inc. (NYSE:BMS). Toronto Dominion Natl Bank reported 19 shares. Metropolitan Life Insurance Co reported 26,225 shares. Pggm Invests owns 255,700 shares or 0.06% of their US portfolio. Lpl Finance Ltd Com reported 25,053 shares stake. 12,050 were reported by Rothschild Inv Corp Il. Sg Americas Ltd Limited Liability Company reported 12,449 shares or 0% of all its holdings. The New York-based Epoch Investment Ptnrs Inc has invested 0.06% in Bemis Company, Inc. (NYSE:BMS). Jnba Fincl Advsrs owns 418 shares for 0% of their portfolio. Bryn Mawr Trust holds 0.28% or 118,273 shares in its portfolio. Retirement Sys Of Alabama has invested 0.05% in Bemis Company, Inc. (NYSE:BMS). Alliancebernstein L P owns 0.01% invested in Bemis Company, Inc. (NYSE:BMS) for 272,124 shares.

Bemis Company, Inc. (NYSE:BMS) Ratings Coverage

Among 4 analysts covering Bemis Co (NYSE:BMS), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Bemis Co had 5 analyst reports since July 30, 2018 according to SRatingsIntel. On Monday, October 29 the stock rating was maintained by Barclays Capital with “Overweight”. The stock of Bemis Company, Inc. (NYSE:BMS) has “Overweight” rating given on Monday, July 30 by Barclays Capital. On Tuesday, August 7 the stock rating was downgraded by UBS to “Neutral”. The stock of Bemis Company, Inc. (NYSE:BMS) earned “Sector Perform” rating by RBC Capital Markets on Wednesday, August 15. As per Tuesday, August 7, the company rating was maintained by Robert W. Baird. Below is a list of Bemis Company, Inc. (NYSE:BMS) latest ratings and price target changes.

29/10/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $55 New Target: $52 Maintain
15/08/2018 Broker: RBC Capital Markets Old Rating: Underperform New Rating: Sector Perform Old Target: $46 Upgrade
07/08/2018 Broker: UBS Old Rating: Buy New Rating: Neutral Old Target: $55 Downgrade
07/08/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Neutral Old Target: $48 New Target: $57 Maintain
30/07/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $52 New Target: $55 Maintain

The stock increased 1.20% or $0.58 during the last trading session, reaching $48.76. About 883,012 shares traded or 41.44% up from the average. Bemis Company, Inc. (NYSE:BMS) has risen 5.21% since December 2, 2017 and is uptrending. It has underperformed by 10.41% the S&P500.

Bemis Company, Inc. manufactures and sells packaging products. The company has market cap of $4.44 billion. It operates through two divisions, U.S. It has a 40.16 P/E ratio. Packaging and Global Packaging.

More notable recent Bemis Company, Inc. (NYSE:BMS) news were published by: which released: “Report: Exploring Fundamental Drivers Behind Bemis, Great Panther Silver, Servotronics, Tengasco, International Tower Hill Mines, and Houston American Energy — New Horizons, Emerging Trends, and Upcoming Developments – Nasdaq” on November 26, 2018, also with their article: “Bristol-Myers’ Collaboration Deal: Accelerating Potential Creation Value For Compugen Ltd. – Seeking Alpha” published on November 27, 2018, published: “Bristol-Myers Squibb (BMY) Presents at Credit Suisse Healthcare Conference (Transcript) – Seeking Alpha” on November 14, 2018. More interesting news about Bemis Company, Inc. (NYSE:BMS) were released by: and their article: “Jeremy Grantham’s 6 Largest Buys of 3rd Quarter –” published on November 21, 2018 as well as‘s news article titled: “Better Buy: Pfizer vs. Bristol-Myers Squibb – The Motley Fool” with publication date: November 25, 2018.

Bemis Company, Inc. (NYSE:BMS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.